INTELLIPACE Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for INTELLIPACE with the United States Patent and Trademark Office. The USPTO has given the INTELLIPACE trademark a serial number of 88197025. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 4, 2025. This trademark is owned by Medpace, Inc.. The INTELLIPACE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmacological research, namely, conducting clinical trials for others
intellipace

General Information

Serial Number88197025
Word MarkINTELLIPACE
Filing DateFriday, November 16, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 4, 2025
Registration Number6043447
Registration DateTuesday, April 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Pseudo MarkINTELLI PACE
Goods and ServicesMedical and pharmacological research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code042
First Use Anywhere DateWednesday, February 27, 2019
First Use In Commerce DateWednesday, February 27, 2019

Trademark Owner History

Party NameMedpace, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45227
Party NameMedpace, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45227
Party NameMedpace, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45227

Trademark Events

Event DateEvent Description
Tuesday, February 26, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 20, 2018NEW APPLICATION ENTERED
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Tuesday, February 26, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 18, 2019ASSIGNED TO LIE
Tuesday, March 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, June 18, 2019USE AMENDMENT FILED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 10, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 10, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, July 15, 2019SU - NON-FINAL ACTION - WRITTEN
Monday, July 15, 2019NON-FINAL ACTION E-MAILED
Monday, July 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 23, 2020ASSIGNED TO LIE
Friday, January 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 23, 2020SU - FINAL REFUSAL - WRITTEN
Sunday, February 23, 2020FINAL REFUSAL E-MAILED
Sunday, February 23, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 26, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Monday, April 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 28, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, September 4, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 4, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 4, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

intellipace clinical trials others conducting namely pharmacological research medical